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We previously reported that herpes simplex virus type 1 (HSV-1) can activate the stress-activated protein
kinases (SAPKs) p38 and JNK. In the present study, we undertook a comprehensive and comparative analysis
of the requirements for viral protein synthesis in the activation of JNK and p38. Infection with the UL36
mutant tsB7 or with UV-irradiated virus indicated that both JNK and p38 activation required viral gene
expression. Cycloheximide reversal or phosphonoacetic acid treatment of wild-type virus-infected cells as well
as infection with the ICP4 mutant vi13 indicated that only the immediate-early class of viral proteins were
required for SAPK activation. Infection with ICP4, ICP27, or ICP0 mutant viruses indicated that only ICP27
was necessary. Additionally, we determined that in the context of virus infection ICP27 was sufficient for SAPK
activation and activation of the p38 targets Mnk1 and MK2 by infecting with mutants deleted for various
combinations of immediate-early proteins. Specifically, the d100 (0/4) and d103 (4/22/47) mutants
activated p38 and JNK, while the d106 (4/22/27/47) and d107 (4/27) mutants did not. Finally,
infections with a series of ICP27 mutants demonstrated that the functional domain of ICP27 required for
activation was located in the region encompassing amino acids 20 to 65 near the N terminus of the protein and
that the C-terminal transactivation activity of ICP27 was not necessary.
The stress-activated protein kinases (SAPKs) p38 and JNK
are part of a larger family of serine/threonine terminal kinases
termed mitogen-activated protein kinases (MAPK), which in-
cludes ERK1 and -2. SAPK pathways are normally activated by
UV irradiation, anoxia, and engagement of proinflammatory
cytokines or Fas ligand by their cognate receptors. Following
ligand binding to a cognate receptor, signaling is initiated
through receptor-associated kinases to a MAPKKK (MAPK
kinase kinase). MAPKKKs capable of initiating the p38 or
JNK pathway include MEKK1, -2, -3, and -4, ASK-1, TAK-1,
and TAO. These in turn activate dual-specificity MAPK kinase
kinases (MAPKKs) MKK3/6 and MKK4/7, which directly bind
and phosphorylate p38 and JNK, respectively, on both tyrosine
and threonine, resulting in their activation (for a review, see
reference 78).
All three subfamilies of human herpesviruses activate one or
more of the MAPKs during infection. The betaherpesvirus
cytomegalovirus activates both p38 and ERK by a mechanism
dependent on viral gene expression (14, 39, 76) and the up-
stream kinases MKK3/6 and MKK1/2, respectively, (39, 40).
ERK activates the early gene UL112-113 promoter (76) and
phosphorylates immediate-early 86 and 72 proteins to alter
their transactivation activity (40), while p38 phosphorylates
retinoblastoma protein and HSP27 (39). ERK and p38 activa-
tion are required for cytomegalovirus DNA replication (16).
The gammaherpesvirus Kaposi’s sarcoma-associated herpesvi-
rus G protein-coupled receptor activates ERK and p38, caus-
ing increased vascular endothelial growth factor expression via
phosphorylation of hypoxia-inducible factor 1 (86). The gam-
maherpesvirus Epstein-Barr virus activates p38 and JNK (1,
21). The immediate-early proteins BZLF1 and BRLF1 induce
increased phosphorylation of p38 and JNK and activation of
the ATF-2 transcription factor (1). BZLF1 expression during
BRLF1-driven virus reactivation requires p38 activity (1).
Among the alphaherpesviruses, HSV-2 has been reported to
activate ERK through ICP10-PK binding to RAS-GAP, lead-
ing to further expression of ICP10 and prevention of apoptosis
(68).
Two previous reports documented the activation of the p38
and JNK (SAPK) pathways by HSV-1. Increased JNK and p38
kinase activity was observed as early as 3 hours postinfection
and remained active throughout the course of infection (56,
97). SAPKs were activated downstream of Ras, as infection
with a dominant-negative form of Ras did not affect activation
of the transcription factors ATF-2 and c-Jun, downstream tar-
gets of p38 and JNK, respectively (56). Furthermore, activation
was specific for SAPKs, as ERK was not activated during
infection (56). Overexpression of JIP-1, a JNK scaffold protein,
suppressed nuclear import of JNK and reduced virus yield
(56). Infection in the presence of small-molecule inhibitors for
p38 (SB203580) and JNK (SP600125) resulted in an 85 to 91%
drop in virus yield depending on cell type (43), suggesting that
activation of the SAPK pathways was essential for efficient
viral replication. Besides a role for the MAPKK MKK4 in JNK
activation (97), little is understood about the mechanism of
SAPK activation in HSV-1-infected cells.
We hypothesize that JNK and p38 are activated by the same
mechanism due to the similarity in their activation kinetics and
the signaling pathways themselves. The delayed kinetics of
JNK and p38 activation (56) suggest that their activation is
dependent on viral gene expression. Among the most likely
candidates are one or more immediate-early proteins, since
significant amounts of these proteins accumulate by 3 hours
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postinfection, well before the accumulation of significant
amounts of delayed-early (DE) or late (L) proteins. Two series
of experiments indicated that neither virus binding per se nor
the presence of virion components in the cell initiated events
leading to JNK activation. In the first, antibody-neutralized
virus, capable of binding to but not entering cells, failed to
activate JNK (56). In the second, infection with the UL36
mutant tsB7 failed to induce JNK activation (56). By contrast,
the ICP4 mutant vi13 activated JNK more efficiently than wild-
type virus, consistent with the ability of this mutant to express
higher levels of the immediate-early proteins than wild-type
virus (85).
To further explore the mechanisms of HSV-induced activa-
tion of the SAPK pathways, we conducted experiments to
identify virus-encoded effector proteins. In this report, we
demonstrate that immediate-early gene expression is sufficient
for the activation of both p38 and JNK. In the context of virus
infection, ICP27 was sufficient and an ICP27 N-terminal func-
tional domain previously shown to be involved in nuclear ex-
port was necessary for SAPK activation.
MATERIALS AND METHODS
Cells and viruses. CV-1 cells were originally obtained from Saul Silverstein
(Columbia University) and were grown in Dulbecco’s modified Eagle’s medium
supplemented with 5% bovine calf serum, 100 U/ml penicillin, 1% streptomycin,
and 1% L-glutamine (all from Gibco). Cells were seeded into 100-mm dishes at
a density of 2  106 cells per plate. Both mock infection and infection with virus
were conducted in spent medium for 1 hour at 37°C. The inoculum was then
replaced with virus-free spent medium.
The KOS 1.1 strain of HSV-1 was used in all experiments unless otherwise
noted. A stock of UV-irradiated virus was prepared and the residual titer was
determined by plaque assay on Vero cells. The resulting titer was reduced 2.94
 103-fold, and therefore when cells were subsequently infected with an amount
of virus corresponding to a multiplicity of infection (MOI) of 5 of the original
stock, the actual (residual) MOI was 0.0017. The mutant tsB7 (9, 47), the
parental HFEM strain of HSV-1, and the KOS ICP27 deletion mutant d27-1 (74)
were provided by David Knipe (Harvard University). The ICP4 mutants vi13,
n12, and d120 (18, 19, 85) were provided by Neal DeLuca (University of Pitts-
burgh). The IE multiple mutants d100 (0/4), d103 (4/22/47), d106 (4/
22/27/47), d107 (4/27), and d109 (0/4/22/27/47) were also provided
by Neal DeLuca (80). The ICP6 mutant ICP6 (27) was provided by Sandra
Weller (University of Connecticut). The ICP0 mutant 7134 (11) was provided by
Priscilla Schaffer (Harvard Medical School). The ICP27 C-terminal truncation
mutants n59r and n504r (74), the in-frame deletion mutants dLeu (51), d1-5, d5-6
(59), d1-2 (71), d2-3, d6-7 (6), d3-4, and d4-5 (58) and the point mutant m11 (70)
were all provided by Stephen Rice (University of Minnesota). The temperature-
sensitive ICP27 mutant vBSLG4 and a partial revertant, vBS3-3 (83, 87), were
provided by Saul Silverstein (Columbia University). A fuller description of these
mutants is provided below.
Inhibitor treatment. Viral gene expression was limited to the immediate-early
phase by treating cells for 30 min prior to infection with 0.5 g per ml of
cycloheximide. The same concentration of drug was present in the inoculum and
replacement medium. At 3 hours postinfection, monolayers were rinsed with
spent medium and then treated with actinomycin D at a concentration of 4 g
per ml of spent medium. To prevent expression of true-late (2) viral genes, the
viral DNA replication inhibitor phosphonoacetic acid (Sigma) was present in the
virus inoculum and replacement medium at a concentration of 400 g per ml
(36).
Preparation of whole-cell lysates and immunoblotting. At the time of harvest,
cells were placed on ice to prevent artifactual induction of stress responses. The
medium was removed and the monolayers were rinsed with ice-cold Dulbecco’s
phosphate-buffered saline. Cells were scraped directly into 1 sodium dodecyl
sulfate (SDS) sample buffer (3.85 mM Tris base, pH 6.8, 9.1% -mercaptoetha-
nol, 1.82% SDS, 4.6% glycerol, and 0.023% bromophenol blue in 100% ethanol)
and proteins were denatured by boiling. Cell-equivalent amounts of lysate were
separated by electrophoresis on 12% SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) or 15% N,N	-diallyltartardiamide (DATD)-cross-linked gels
(Mnk1 and MK2 probes only). Proteins were transferred to PolyScreen polyvi-
nylidene difluoride membranes (PerkinElmer Life Sciences) followed by block-
ing in TBST (150 mM NaCl, 20 mM Tris [pH 7.6], 0.05% Tween 20) with 5%
milk. All probing and washing of membranes were done in TBST. Antibodies for
p38 (9212), phospho-p38 (9211), JNK (9252), phospho-JNK (9251), phospho-
MK2 (3041), and phospho-Mnk1 (2111) were purchased from Cell Signaling
Technology and used at a 1:1,000 dilution overnight at 4°C per manufacturer’s
instructions. Polyclonal antibody for Mnk1 (sc-6965) was purchased from Santa
Cruz Biotechnology and used at a 1:500 dilution. Monoclonal antibody for
-tubulin (B-5-1-2, Sigma) was used at a 1:20,000 dilution. Monoclonal antibod-
ies for the viral proteins ICP0 (1112), ICP4 (1101), and ICP27 (1113 and 1119)
were purchased from the Rumbaugh-Goodwin Institute for Cancer Research
and used at 1:800, 1:800, 1:800, and 1:4,000 dilutions, respectively. Polyclonal
antibody for VP16 (Clonetech) was used at a 1:5,000 dilution. Polyclonal anti-
body against ICP8 (3–83) was a generous gift from David Knipe and was used at
a 1:20,000 dilution. Polyclonal antibody against gC (R47), used at 1:5,000, was a
generous gift of Gary Cohen and Roselyn Eisenberg (University of Pennsylva-
nia).
Goat anti-rabbit and anti-mouse immunoglobulin secondary antibodies were
purchased from Amersham Biosciences and used at a 1:5,000 dilution. Secondary
antibody was detected using SuperSignal West Pico chemiluminescent substrate
agent (Pierce). Films were scanned and images were stored as eight-bit grayscale
.jpg files for quantification. The density of each band was determined using
Image J (National Institutes of Health). Relative density values were corrected
for average background by subtracting the density of a blank portion of the film.
From the corrected values, a phosphorylation-specific to total ratio was calcu-
lated for the SAPKs. These ratios were then used to calculate either average fold
increase (sample value/mock-infected cells value 
 standard deviation) or aver-
age percent of control sample levels from independent experiments, using Mi-
crosoft Excel. For viral genes, background-corrected values were used to calcu-
late average percent of wild-type KOS sample levels from independent
experiments using Microsoft Excel.
RESULTS
HSV gene expression is required for p38 activation. While
we previously established the requirement of viral gene expres-
sion for JNK activation (56), the requirements for p38 activa-
tion were assessed here. We first determined whether the
mechanisms of p38 activation relied either on virion binding to
a cell surface receptor or on delivery of tegument proteins to
the infected cell. The mutation in HFEM tsB7 maps to UL36,
and this virus expresses a temperature-sensitive VP1/2, a teg-
ument protein required for release of the viral genome from
the capsid and its delivery into the nucleus (9, 57). Thus, at the
nonpermissive temperature, mechanisms of binding and entry
are normal, but viral gene expression is prevented (47). Nota-
bly, tsB7 delivers the tegument protein VP16 to the nucleus at
the nonpermissive temperature (9). We also monitored the
activation of JNK in these experiments as a positive control in
order to more closely correlate the present findings with our
previously published results.
Parallel cultures of CV-1 cells were mock infected or in-
fected with the parental wild-type HFEM strain of HSV or the
tsB7 mutant at an MOI of 5 at 33, 37, or 39°C, and whole-cell
extracts were harvested at 8 hours postinfection. We chose this
time because in our previous studies we observed maximal
JNK activity and phosphorylated p38 after 7 h postinfection
(56). To evaluate activation of the JNK and p38 pathways,
proteins were separated by SDS-PAGE and Western blotted
for phosphorylated forms of JNK and p38. We monitored for
total levels of JNK and p38 protein to ensure that any change
in phosphorylated protein levels seen was an actual measure of
activation. Levels of -tubulin were monitored for equal pro-
tein loading on gels.
As a measure of viral protein synthesis, the level of ICP27
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remained high in HFEM infections at all temperatures (Fig. 1,
lanes 4 to 6), but steadily decreased in tsB7 samples and was
not detectable in tsB7 infections at 39°C (Fig. 1, lanes 7 to 9).
We observed a slight activation of p38 in the mock-infected
samples as a function of increasing temperature (lanes 1 to 3).
We corrected for the difference during quantification of the
image bands by normalizing for total p38 or JNK and for
protein loading (-tubulin) before calculating the reduction in
activation during mutant infection. The results of the quanti-
fication can be found under the corresponding band in Fig. 1.
Consistent with the phenotype of tsB7 and a role for viral
gene expression for JNK activation, we observed decreased
amounts of activated SAPKs, relative to the parental virus
HFEM, in mutant virus infections performed at increasingly
higher temperatures (Fig. 1, compare lanes 7 to 9). Three
distinct JNK species were observed: a minor rapidly migrating
species and two relatively abundant slower-mobility bands. In-
creased phosphorylation of all three forms was observed at all
temperatures in HFEM but only at 33° in tsB7 infection. De-
spite correcting for the increase in basal activation of p38,
significant though decreasing activation of p38 was observed as
the temperature of infection was raised from 33 to 39°C. We
repeated the above experiment at an MOI of 10 (data not
shown) and observed similar results.
We evaluated p38 and JNK activation by a second method.
As with tsB7, infection with UV-irradiated wild-type virus
should still account for all the events prior to viral gene ex-
pression, including delivery of tegument proteins, but without
the further complication that a change in temperature may
introduce into the experimental design. We either mock in-
fected or infected CV-1 cells with wild-type KOS at an MOI of
5, with an equivalent amount of UV-irradiated virus, calcu-
lated to have a residual MOI of 0.0017 (see Materials and
Methods), or with unirradiated KOS at an MOI of 0.0017, and
compared levels of JNK and p38 activation at 8 h postinfection
(Fig. 2).
We confirmed the phenotype of each infection by probing
for either IE ICP27 or DE ICP8. We also detected VP16 in
both KOS and UV-irradiated KOS (MOI  5)-infected cells
(data not shown), demonstrating that tegument proteins and
the viral genome were being released into the host cell during
infection. No detectable activation of JNK was observed in the
lysates from mock-infected, UV-irradiated virus or KOS infec-
tion at the residual MOI (lanes 1 to 3), while the lysate from
cells infected with wild-type KOS at an MOI of 5 contained
activated JNK (lane 4). The same results were observed for the
activation of p38 (lanes 5 to 8). The activation seen in normal
wild-type infection was directly correlated with the onset of
viral gene expression, indicating through two independent
methods that the involvement of VP16 (97) in the activation of
either p38 or JNK represents its ability to activate immediate-
early gene expression. These data were also consistent with our
previously reported findings that neither JNK nor p38 was
activated at any time during the first 60 min of infection (56).
Immediate-early gene expression is sufficient for SAPK ac-
tivation. The previous experiments could not determine
whether the same viral proteins were involved in activating
JNK and p38 during infection. To address this question, we
first conducted a series of infections to determine which kinetic
classes of proteins, IE, DE, or L, were necessary for the acti-
vation of the SAPKs. Previously, we demonstrated that JNK
and p38 activation occurred within 3 hours postinfection, with
maximal activation occurring 6 to 8 hours postinfection (56).
Therefore, HSV initiates SAPK activation early in infection,
FIG. 1. SAPK activation is dependent on viral gene expression.
Replicate CV-1 cultures were mock infected or infected with HFEM
or tsB7 at 33, 37, or 39°C as indicated, and lysates were prepared at 8 h
postinfection. Western blot analysis of proteins was as described
in Materials and Methods. A representative of three independent
experiments is shown. Band intensities of phospho-JNK (pJNK) and
phospho-p38 (pp38) were quantified using Image J as described in
Materials and Methods, and results are presented as a percentage of
wild-type parental virus (HFEM) values below the corresponding tsB7
lanes (7–9).
FIG. 2. Infection with UV-irradiated HSV does not result in SAPK
activation. Replicate cultures of CV-1 cells were mock infected, in-
fected with wild-type HSV-1 at the indicated MOIs, or infected with
UV-irradiated HSV as described in the text. Lysates were prepared at
8 h postinfection, and levels of the indicated proteins were determined
by Western blot.
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when predominantly immediate-early proteins are expressed,
though maximal activation correlates with the onset of early
and some late gene expression. We hypothesized that SAPK
activation was initiated by one or more IE proteins but may
require the expression of DE or L proteins to achieve maximal
activation.
Treatment with the protein synthesis inhibitor cyclohexi-
mide allows accumulation of IE mRNA, since transcription of
viral mRNA does not require de novo viral protein synthesis
for expression (35). If the block to protein synthesis is then
reversed in the presence of a DNA-dependent transcription
inhibitor, actinomycin D, to prevent IE proteins from activat-
ing DE or L gene expression, only IE proteins are expressed.
Treatment with phosphonoacetic acid, a viral DNA synthesis
inhibitor, allows expression of IE, DE, and the 1 class of L
protein but no 2 gene expression (36).
Whole-cell lysates were prepared in three separate experi-
ments and analyzed by Western blot for expression of each
class of viral protein. Representative Western blots can be
found in Fig. 3. Mock-infected cells expressed no viral proteins
(Fig. 3, lanes 1 and 5), while wild-type KOS-infected untreated
cells expressed ICP0, ICP8, and VP16 (Fig. 3, lanes 2 and 6).
Cells treated with cycloheximide and then reversed in the pres-
ence of actinomycin D expressed ICP0 but no detectable ICP8
or VP16 (Fig. 3, lane 3 and 7). The levels of ICP0 were similar
in untreated wild-type, cycloheximide reversal, and phospho-
noacetic acid-treated infected cells. Phosphonoacetic acid-
treated cells accumulated both ICP0 and ICP8 but only low
levels of VP16 (Fig. 3, lanes 4 and 8), as expected for a 1
protein. JNK and p38 activation observed in the infected sam-
ples was increased over that of the mock-infected samples
regardless of treatment in three independent experiments. Ad-
ditionally, when the ratio of phosphorylated to total JNK or
p38 was determined by Image J (Materials and Methods), we
found no difference between untreated and drug-treated in-
fected cells. Subjecting uninfected cells to cycloheximide re-
versal or phosphonoacetic acid treatment did not induce acti-
vation of either pathway (data not shown). Therefore, we
concluded that activation of both JNK and p38 was due to
expression of one or more immediate-early proteins.
To confirm this observation, we infected cultures of CV-1
cells in triplicate with either wild-type KOS or the ICP4 mutant
vi13. An insertion mutation at amino acid 338 and a nonsense
mutation at amino acid 774 disrupt the DNA binding activity of
ICP4, resulting in the overexpression of IE proteins and no DE
or L (85). At 8 h postinfection, we observed accumulation of
ICP27 in both wild-type KOS-infected and vi13-infected cells
(Fig. 4, lanes 2 to 3), but no detectable ICP8 in vi13-infected
cells (Fig. 4, lane 6). The higher accumulation of ICP27 in
vi13-infected samples compared to wild-type virus was consis-
tent with other reports using this mutant (56). Significant phos-
phorylation of JNK and p38 over mock-infected cells was ob-
served in both wild-type KOS- and vi13-infected cells (Fig. 4,
lanes 2 to 3 and 5 to 6). We calculated the average activation
over wild-type KOS of phospho-p38 (1.32-fold) and JNK (1.01-
fold) in vi13-infected cells, normalized to total p38 and JNK
levels from triplicate samples. The higher levels of SAPK ac-
tivation observed in vi13-infected cells correlated with the
higher level of ICP27 or other IE proteins (56), consistent with
immediate-early protein-dependent SAPK activation during
HSV infection.
ICP27 is required for p38 and JNK activation. In the pre-
vious sections, we demonstrated that IE protein expression was
sufficient for activation of p38 and JNK. To identify the IE
proteins critical for SAPK activation, CV-1 cells were infected
with the following panel of immediate-early mutant viruses: (i)
n12, a nonsense mutant which expresses a 41-kDa ICP4
protein representing amino acids 1 to 251 (19); (ii) 7134, which
contains a lacZ substitution for the ICP0 open reading frame
(11); (iii) ICP6, which is deleted for the ICP6 open reading
FIG. 3. Immediate-early gene expression is sufficient for SAPK ac-
tivation. Replicate cultures of CV-1 cells were mock infected or in-
fected with HSV under the conditions indicated and described in
Materials and Methods. Lysates were prepared at 8 h postinfection,
and accumulation of the indicated proteins was determined by Western
blot. HSV/Cx reversal, infection of cells in the presence of cycloheximide
followed by removal of cycloheximide and addition of actinomycin D;
HSV  PAA, infection of cells in the presence of phosphonoacetic
acid.
FIG. 4. SAPK activation occurs after infection with an ICP4 mu-
tant virus. Replicate cultures of CV-1 cells were mock infected or
infected with wild-type KOS or ICP4 mutant vi13. Lysates were pre-
pared at 8 h postinfection, and levels of the indicated proteins were
determined by Western blot.
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frame (27); and (iv) d27-1, which is deleted for the entire
ICP27 gene (74). The n12 mutant was reported to express only
IE proteins and the DE protein ICP6 (18, 19).
Following infection with wild-type and mutant viruses at an
MOI of 10, whole-cell lysates were prepared at 8 h postinfec-
tion, separated by SDS-PAGE, and Western blotted for phos-
pho-specific forms of p38 and JNK. Mock-infected cells exhib-
ited little detectable phosphorylated p38 or JNK (Fig. 5A, lane
1) and, for the purposes of comparison (Table 1, experiment
1), were assigned a value of 1. Levels of total p38 and JNK
were comparable in all samples (Fig. 5, lanes 1 to 7). Wild-type
infection induced phosphorylation of both JNK and p38 (Fig.
5, lane 2). The n12 and 7134 mutants were also efficient at
inducing JNK and p38 activation (Fig. 5, lanes 3 to 4, and Table
1, experiment 1), while ICP6 infection resulted in signifi-
cantly reduced JNK but not p38 activation relative to wild-type
virus (Fig. 5, lane 5). Infection with the ICP27 mutant d27-1
failed to activate either stress kinase (Fig. 5, lane 6).
Previous reports concerning the ICP6 mutant indicated a
general depression in viral protein expression and delayed
kinetics of infection compared to wild-type virus (26). To de-
termine if the lower JNK activation after ICP6 infection was
due to a delay in kinetics, we conducted a time course exper-
iment with the same panel of immediate-early mutants this
time at an MOI of 5, harvesting samples at 6, 8, and 12 h
postinfection and analyzing for phospho-JNK and phospho-
p38 by Western blot. The results were quantified as described
in Materials and Methods, and the data are presented in Table
1, experiment 2. We observed a continual increase in p38
activation in the wild-type KOS-, n12-, 7134-, and ICP6-
infected cells over the time course. However, there was no
increase in p38 activation in cells infected with d27-1 except at
24 h postinfection. We suggest that this may be related to a
stress response induced by the absence of ICP27 at late times
of infection.
While elevated levels of activated JNK were observed
throughout the wild-type virus time course, a continual increase in
activated JNK was observed in n12-, 7134-, and ICP6-infected
cells. By 24 h postinfection, wild-type infection as well as n12,
7134, and ICP6 infections all activated JNK to similar levels,
while d27-1 infection failed to significantly activate JNK at any
time after infection. We interpreted these results to indicate
FIG. 5. ICP27 is necessary for JNK and p38 phosphorylation after HSV infection. (A) Replicate cultures of CV-1 cells were mock infected or
infected with the indicated viruses as described in the text. Whole-cell lysates were prepared at 8 h postinfection, and accumulation of
phosphorylated forms of p38 and JNK was determined by Western blot. Anisomycin was used as a positive control for p38 activation. Cells were
treated with anisomycin (20 g/ml) for 20 min prior to harvest. (B) Lysates prepared at 8 h postinfection were probed for the indicated viral
proteins by Western blot.
TABLE 1. Activation in wild-type and mutant virus-infected cellsa
Virus (affected gene)
Relative abundance at time postinfection:






6 h 8 h 12 h 24 h 6 h 8 h 12 h 24 h
None 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
Wild-type KOS 2.3 87.6 3.4 5.2 11.8 14.2 11.2 10.6 7.2 8.5
n12 (ICP4) 3.8 57.7 1.2 5.4 7.6 11.1 0.7 1.3 5.2 5.4
7134 (ICP0) 2.9 35.0 3.1 4.6 7.1 12.5 0.0 0.8 3.2 6.2
ICP6 (ICP6) 1.6 14.4 2.1 2.3 7.1 5.4 0.0 0.6 2.4 6.8
d27-1 (ICP27) 0.1 0.3 1.5 0.2 0.1 10.2 0.0 1.0 1.2 2.0
a Values represent levels of phospho-p38 and phospho-JNK at each time postinfection relative to mock-infected cells. Accumulation of proteins in whole-cell lysates
prepared at 6, 8, 12, and 24 h postinfection was determined by Western blot and quantified as described in Materials and Methods.
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that the lower activation of JNK observed at 8 h in experiment
1 can be attributed to a delay in viral protein synthesis in the
ICP6 infection (26) and not to a requirement of ICP6 for the
activation of SAPK proteins. Support for this conclusion was
obtained by probing for glycoprotein C (gC), a late protein. We
observed decreased gC accumulation in ICP6-infected cells
compared to wild-type-infected cells (Fig. 5B, compare lanes 2
and 5). Between the two experiments, we observed the same
trend in SAPK activation, with the differences in activation
between experiments most likely due to differences in MOI
and variations from experiment to experiment in the amount of
activated SAPK in mock-infected samples.
To confirm the status of viral protein synthesis under con-
ditions of wild-type and mutant virus infection, lysates pre-
pared at 8 h postinfection were also probed for accumulation
of ICP27, ICP4, ICP0, and ICP8 (Fig. 5B). All Western blots
for viral proteins were intentionally overexposed to ensure that
no low-level expression of the corresponding deleted protein
was detectable. Shorter exposure times show variable accumu-
lation of ICP27 in some mutant infections (data not shown).
The n12 mutant expresses a 35-kDa, truncated form of ICP4
that was not detectable on the 10% SDS-PAGE gel used.
Additionally, n12 failed to express ICP8, confirming its ex-
pected phenotype. Since d27-1 was the only immediate-early
mutant to consistently fail to activate p38 and JNK, we con-
cluded that ICP27 was necessary for activation of the SAPK
pathways.
ICP27 is sufficient for SAPK activation. Next, we sought to
determine if in the context of virus infection ICP27 was suffi-
cient for the activation of JNK and p38 by taking advantage of
a series of multiple-deletion mutants (80) for immediate-early
proteins (Table 2). Lysates from infected cells were prepared
at 8 h postinfection, separated by SDS-PAGE, and Western
blotted for phospho-specific forms of the SAPKs. Figure 6
displays representative data from three independent experi-
ments. The d100 mutant was examined at MOIs of 5, 10, and
20. Since d100 expresses ICP27, ICP22, and ICP47, infections
with ICP22 and ICP47 deletion mutants were performed. We
observed p38 and JNK activation using either an ICP22 or
ICP47 mutant comparable to that of wild-type virus infection
(data not shown), suggesting that neither of these IE proteins
was involved in SAPK activation. We concluded from this that
d100 was an appropriate way of evaluating the sufficiency of
ICP27 in SAPK activation in the context of virus infection.
When we evaluated phospho-JNK in these lysates, very low
levels of activated JNK were observed in mock-, d27-1-, or
d100-infected cells at any MOI used (Fig. 6A, lanes 1 and 3 to
6), while significant activated JNK was seen in the wild-type
lysate (Fig. 6A, lane 2). Similarly, we observed very low acti-
vation of p38 in mock- and d27-1-infected cells (Fig. 6A, lanes
1 and 3). However, we did observe 62, 78, and 44% of wild-type
p38 activation in d100 infections at MOIs of 5, 10, and 20,
respectively (compare lane 2 with lanes 4 to 6). Expression of
ICP0, ICP4, and ICP27 mRNAs was examined in parallel cul-
tures by reverse transcription-PCR. ICP27 mRNA accumu-
lated after d100 infection, but mRNA for ICP0 and ICP4 did
not (data not shown), confirming the genotype of the d100
virus. We also observed that ICP27 mRNA levels were lower in
an MOI of 5 with d100 compared to wild-type KOS infection,
and this result was confirmed by Western blots for ICP27 (Fig.
6A).
To determine whether longer d100 infections resulted in
activated JNK, we compared mock-, wild-type-, d27-1-, and
d100-infected cells at 16 h postinfection as well as d100-in-
fected cells at 24 h postinfection, all at an MOI of 5. Increased
expression of ICP27 in d100 infections was observed by West-
ern blot at these later times compared to 8 h postinfection
(compare Fig. 6A lane 4, with 6B, lanes 4 to 5). We also
detected phospho-JNK in wild-type KOS and d100 lysates at
both later time points (Fig. 6B, lanes 2, 4, and 5). Mock-
infected and d27-1 lysates contained lower levels of phospho-
JNK (Fig. 6B, lanes 1 and 3). When we blotted for phospho-
p38, no activation in the mock-infected cells (Fig. 6B, lane 1)
was observed, but significant activation was evident in all in-
fected samples (Fig. 6B, lanes 2 to 5), including the ICP27
deletion mutant d27-1.
To determine if the activation of p38 seen in d27-1-infected
cells at late times postinfection was similar to that of wild-type
or d100 infections, we probed for levels of phospho-MNK, a
downstream target of p38 known to be activated during infec-
tion (92), and a second downstream target MAP kinase-acti-
vated protein (MAPKAP) kinase 2 (MK2) (24, 77), which has
not previously been evaluated during HSV infection. As seen
in Fig. 6C, we detected a series of closely migrating bands,
around 45 kDa, in all lanes when probing membranes with
either phospho-MNK or total MNK antibody. We detected an
additional slower-mobility band in the wild-type KOS- and
d100-infected samples at 16 h pi, as well as the d100-infected
samples at 24 h pi, indicated by the asterisks (Fig. 6C, lanes 2,
4, and 5). Probing for phospho-MK2, we again observed a
series of closely migrating bands, around 48 kDa, in all lanes,
with an additional slower-mobility band appearing specifically
in the wild-type KOS- and d100-infected lysates (Fig. 6C). This
suggests that the mechanism of p38 activation in d27-1-in-
fected cells at late times postinfection was different from the
ICP27-induced activation of p38 in wild-type- and d100-in-
fected cells. From these results, we concluded that ICP27 is
sufficient for the activation of both JNK and p38.
To confirm that ICP27 was sufficient for SAPK activation,
we compared mock-, wild-type-, d103-, d106-, d107-, and d109-
infected cells for levels of phospho-p38 and JNK at 8 h postin-
fection. As seen in Fig. 6C, only wild-type and d103-infected
cell lysates contained activated p38 and JNK (lanes 2 and 3),
while cells infected with viruses deleted for ICP27 (d106, d107,
or d109) contained activated p38 and JNK comparable to
mock-infected cell levels (Fig. 6C, compare lane 1 with lanes 4
to 6). We confirmed the gene deletions for each virus by West-
ern blot for ICP27 and ICP0 (Fig. 6C), and ICP4 (data not




d27-1 0, 4, 22, 47 27 74
d100 22, 27, 47 0, 4 80
d103 0, 27 4, 22, 47 80
d106 0 4, 22, 27, 47 80
d107 0, 22, 47 4, 27 80
d109 0, 4, 22, 27, 47 80
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shown). From these results, we confirmed that ICP27 expres-
sion was sufficient for activation of SAPKs.
ICP27 transactivation function is not essential for JNK or
p38 activation. ICP27 has many roles during the course of the
HSV-1 replication cycle. In addition to being necessary for
transcription of 1 and 2 viral genes (79), ICP27 regulates
polyadenylation site selection (22, 31, 55), regulates the in-
tranuclear distribution of splicing factors (52, 82), interacts
with the export factor Aly/Ref (13), shuttles between the nu-
cleus and cytoplasm (60, 69, 87), and demonstrates RNA bind-
ing activity (59). These functions are consistent with a role of
ICP27 in suppressing cellular posttranscriptional processing
FIG. 6. ICP27 is sufficient for SAPK activation. (A) Replicate cultures of CV-1 cells were mock infected or infected with wild-type KOS (MOI
 5), d27-1 (MOI  5), or d100 (MOI  5, 10, and 20). Whole-cell lysates were prepared at 8 h postinfection, and Western blotting was performed
to detect phospho-p38, phospho-JNK, or the indicated viral protein. (B) Replicate cultures of CV-1 cells were mock infected or infected with
wild-type KOS, d27-1, or d100 at an MOI of 5 and harvested at 16 h postinfection or infected with d100 at an MOI of 5 and harvested at 24 h
postinfection. Lysates were prepared and analyzed as in panel A. (C) Samples from the experiment in panel B were separated on 15%
DATD-cross-linked gels and probed with phospho-MNK1, MNK1, or phospho-MK2 antibody. ICP27-dependent phosphorylated species are
indicated with an asterisk. (D) Replicate cultures of CV-1 cells were mock infected or infected with wild-type KOS, d103, d106, d107, or d109 at
an MOI of 5, and lysates were prepared at 8 h postinfection and analyzed as in panel A.
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and transport while promoting viral transcription. Indeed,
ICP27 may directly stimulate late gene expression through
interaction with RNA polymerase II (99). ICP27 also plays a
role in controlling the subcellular localization of other viral
proteins. Normally, ICP4 and ICP0 are found in both the
nucleus and the cytoplasm. Infection with ICP27 mutants, how-
ever, results in accumulation of ICP0 and ICP4 exclusively in
the nucleus (100–102). Finally, ICP27 is implicated in the post-
translational modifications of ICP0 and ICP4, and it has been
suggested that, in the absence of ICP27, ICP4 may not be
phosphorylated (65, 73).
To determine whether stimulation of p38 and JNK by ICP27
was due to ICP27-induced L gene expression, we utilized two
mutants of ICP27. The vBSLG4 mutant contains a point mu-
tation, R480H, which at the nonpermissive temperature results
in failure to shut off host cell protein synthesis and to activate
late gene expression (83, 87). The vBS3-3 revertant has a
second-site intragenic mutation, V496I, which allows expres-
sion of late genes at the nonpermissive temperature but does
not allow shut off of host cell protein synthesis (83, 87). CV-1
cells were mock infected or infected with either vBS3-3 or
vBSLG4 at 33 or 39°C and harvested at 8 h postinfection for
analysis by Western blot. Both vBS3-3 and vBSLG4 signifi-
cantly activated both JNK and p38 at both the permissive
(33°C) and nonpermissive (39°C) temperatures (Fig. 7A, lanes
3 to 6 and 9 to 12). There were no observable changes in total
levels of either SAPK or -tubulin, suggesting that the
vBSLG4 mutant was capable of activating JNK and p38 despite
the loss of its transcription activation function. The mutants
showed slightly reduced levels of ICP27 at 33°C (Fig. 7A, lanes
3 and 5), likely due to reduced kinetics of infection at this
temperature. As previously observed by others, vBSLG4 ex-
pressed greatly reduced levels of gC (Fig. 7A, lanes 11 to 12)
(79).
To confirm that the transactivation function of ICP27 was
nonessential for SAPK activation, we either mock infected
cells or infected cells with wild-type KOS or the ICP27 mutants
d27-1 and m11. The last contains two point mutations (R340L
and D341E) that prevent the expression of certain 2 genes
(75). At 8 h postinfection, neither mock infection nor infection
with d27-1 resulted in detectable activation of JNK or p38, as
seen by phospho-specific Western blot (Fig. 7B, lanes 1, 3, 5,
and 7). However, infection with either wild-type or m11 virus
resulted in significant activation of both JNK and p38 (Fig. 7B,
lanes 2, 4, 6, and 8). ICP27 expression in m11-infected cells was
detectable, though at a reduced level compared to wild-type
KOS (lanes 2 and 4). Late proteins gC and VP16 were detected
in wild-type and m11 lysates, although in the latter case at
somewhat reduced levels. Neither protein was detectable in the
d27-1-infected cell lysate (Fig. 7B, compare lanes 6 to 8).
Based on these results, we concluded that the transactivation
function of ICP27 was not required for the activation of SAPKs
during HSV infection.
Amino acids 12 to 63 in the N terminus of ICP27 are re-
quired for SAPK activation. To identify the domains of ICP27
required for the activation of SAPKs, we analyzed a series of
ICP27 truncation and in-frame deletion mutants. Table 3 lists
the deleted and mutated regions of ICP27. CV-1 cells were
mock infected or infected with wild-type HSV-1 or the panel of
ICP27 mutants at an MOI of 5. Whole-cell lysates were pre-
FIG. 7. Late gene activation function of ICP27 is not required for
SAPK activation. (A) Replicate cultures of CV-1 cells were mock
infected or infected with either vBS3-3 or vBSLG4 at 33 or 39°C as
indicated. Whole-cell lysates were prepared at 8 h postinfection, and
Western blotting was performed to detect phospho-JNK (left panel)
and phospho-p38 (right panel) or accumulation of the indicated viral
proteins. (B) Replicate cultures of CV-1 cells were mock infected or
infected with wild-type KOS, d27-1, or m11 virus. Whole-cell lysates
were prepared at 8 h postinfection, and Western blotting was per-
formed to detect phospho-JNK (left panel) and phospho-p38 (right
panel) or accumulation of ICP27, gC, or VP16.
TABLE 3. ICP27 mutants





d27-1 1-512 D 74
C-terminal truncation
n59r 60-512 D 74
n504r 505-512 D 74
In-frame deletion
dLeu 6-19 I 51
d1-5 13-153 D 59
d1-2 12-63 I 71
d2-3 64-109 C 6
d3-4 109-138 C 59
d4-5 139-153 D 59
d5-6 154-173 C 59
d6-7 174-200 C 6
Point mutation
m11 aa340, 341 D 75
vBSLG4 aa480 Cc 81, 87
a Amino acid (aa) residues deleted.
b Based on plaquing ratio (Vero/V27) (4, 29). D, defective for growth on Vero
cells; I, inefficient growth on Vero cells; C, competent for growth on Vero cells.
c At 33.5°C.
VOL. 79, 2005 HSV ACTIVATION OF SAPKs 8355
pared at 8 h postinfection, separated by SDS-PAGE, and an-
alyzed by Western blot for phospho-specific forms of p38 and
JNK (Fig. 8A). The experiment was repeated twice, and the
data shown in Fig. 8 were reproducible.
Mock-infected cells contained little or no detectable phos-
phorylated JNK or p38 (Fig. 8A, lanes 1, 8, 13). Wild-type
virus-infected cells contained high levels of activated p38 and
JNK (Fig. 8A, lanes 2, 9, and 14), as did cells infected with the
truncation mutant n504r (Fig. 8A, lane 17) and the in-frame
deletion mutants dLeu, d2-3, d4-5, d5-6, and d6-7 (Fig. 8A,
lanes 3, 6, and 10 to 12). We consistently observed reduced
levels of pJNK and pp38 in d3-4-infected cells (Fig. 8A, lane 7)
compared to wild-type lysates. Nevertheless, this was still sub-
stantially increased over the mock-infected cell control. Ly-
sates from cells infected with the in-frame deletion mutants
d1-5 (Fig. 8A, lane 4) and d1-2 (Fig. 8A, lane 5) and the
C-terminal truncation mutant n59r (Fig. 8A, lane 16) con-
tained little to no phosphorylated JNK or p38. In this analysis,
in contrast to other experiments (Fig. 5 and 7), we detected a
low level of phosphorylated p38 in cells infected with the null
mutant d27-1 (Fig. 8A, lane 15). The low level of p38 activation
seen in d27-1-infected cells may be a mild stress response to
abortive infection. The same stress response was not seen when
phospho-JNK levels were evaluated, perhaps indicating a
higher propensity for p38 activation during abortive infection.
This minor stress response was not observed in other infections
with d27-1 (see Fig. 5 to 7) and was deemed to be nonspecific
due to its variable nature.
ICP27 mutant infections were typed for expression of ICP0,
ICP4, and ICP27 to ensure mutant phenotypes (Fig. 8B and
C). All ICP27 mutants expressed ICP0 and ICP4 at fairly
comparable levels at an MOI of 5 except d1-5 (Fig. 8C). Sim-
ilarly, all mutants expressed comparable amounts of ICP27 of
the expected molecular weight (Fig. 8B). ICP27 expressed by
d3-4 lacks the H1113 epitope and so was only detected by the
H1119 monoclonal antibody (Fig. 8B, lane 7). Conversely,
dLeu lacks the H1119 epitope and was detected with the
H1113 antibody (Fig. 8B, lane 3). Mutant d1-5 failed to acti-
vate SAPKs (Fig. 8A, lane 4). However, as can be seen in Fig.
8B, at an MOI of 5 this mutant also failed to express detectable
levels of ICP27. Therefore, loss of amino acids 12 through 63
(mutant d1-2) was sufficient to prevent ICP27-dependent acti-
vation of p38 and JNK.
DISCUSSION
In this report, we sought to identify the HSV-encoded pro-
teins necessary for inducing activation of the stress-activated
protein kinases JNK and p38, previously reported by our group
and others. Through the use of the tsB7 mutant and UV-
inactivated virus, we demonstrated that SAPK activation dur-
ing infection required viral gene expression and therefore was
not a consequence of cellular stress induced by virus binding or
entry. We also demonstrated that only IE gene expression was
necessary through the use of the ICP4 vi13 mutant and inhib-
itors of protein and DNA synthesis.
While p38 activation was observed in cells infected with an
ICP27 deletion mutant at late times postinfection, we do not
believe that this induction is identical to the ICP27-induced
activation of p38. Since JNK is not activated at late times with
the d27-1 mutant, nor are the downstream targets of p38,
MNK, and MK2, we conclude that the p38 activation observed
in d27-1-infected cells at 16 h postinfection is a generalized
stress response, possibly induced by the onset of apoptosis.
This idea is consistent with the observation that ICP27 deletion
mutants induce apoptosis in other cell types (4, 5, 28).
We demonstrated that ICP27 expression was sufficient, in
the context of viral infection, for SAPK activation. Specifically,
viruses expressing ICP27 but not ICP4 (d103) or expressing
ICP27 but neither ICP4 nor ICP0 (d100) induced SAPK acti-
vation, while viruses that did not express ICP27 and ICP4
(d107) or only expressed ICP0 (d106), failed to induce SAPK
activation. Two other immediate-early proteins, ICP47 and
ICP22, are responsible for blocking the function of the trans-
FIG. 8. Amino acids 20 to 63 of ICP27 are required for SAPK
activation. (A) Analysis of the null mutant d27-1, the in-frame deletion
mutants dLeu, d1-5, d1-2, d2-3, d3-4, d4-5, d5-6, and d6-7, and the
C-terminal truncation mutants n59r and n504r. Replicate cultures of
CV-1 cells were mock infected or infected with the indicated viruses at
an MOI of 5. Whole-cell lysates were prepared at 8 h postinfection,
separated on a 12% gel, and transferred to a membrane for Western
blot analysis as described in Materials and Methods. Membranes were
sequentially probed for phosphorylated and nonphosphorylated forms
of p38 and JNK. (B) Accumulation of ICP27 was verified using mono-
clonal antibodies H1113 (top panel) and H1119 (bottom panel).
(C) Analysis of ICP0 and ICP4 accumulation from null, in-frame, and
truncation mutants.
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porter associated with antigen processing (TAP) (32) and
modifying the C-terminal domain of RNA polymerase II (72),
respectively. Analysis of ICP22 and ICP47 null mutants re-
vealed that they were as efficient as wild-type virus in activating
SAPKs (McLean and Bachenheimer, unpublished observa-
tions).
Distinct functional domains of ICP27 have been identified.
The N terminus of ICP27 includes a leucine-rich domain im-
portant for nuclear export, an RGG box RNA binding site
(59), a nuclear localization sequence, and a casein kinase 2
interaction site (91). The C terminus contains the transcrip-
tional activation and repression domains, the amino acid res-
idues important in spliceosome inhibition, and a zinc finger.
ICP27 is posttranslationally modified in several ways. ICP27 is
nucleotidylated (10) and methylated in vivo (59) and also phos-
phorylated at multiple sites (98). It is an in vivo substrate for
casein kinase 2 (48), and ICP27 participates in the redistribu-
tion of casein kinase 2 in the cytoplasm of the infected cell
(48).
A region of the amino terminus of ICP27 that includes the
acidic region but not the nearby leucine-rich motif was shown
to be required for SAPK activation. This conclusion was based
on analysis of a series of in-frame deletion mutants. The d1-2
region has also been identified as necessary for the suppression
of apoptosis in infected Hep-2 cells (6). Conversely, the C-
terminal transcription activation domain of ICP27 was shown
to be nonessential for SAPK activation, based on the proper-
ties of viruses expressing amino acid substitution mutants of
ICP27. Two ICP27 truncation mutants, n263r and n406r (74),
are deleted for the region involved in the transcriptional reg-
ulation of late genes. The n263r mutant is not stably expressed
in infected cells (S. Rice, personal communication, and data
not shown). The n406r mutant does not shuttle efficiently be-
tween the cytoplasm and the nucleus because of its inability to
bind Aly/Ref (R. Sandri-Goldin, personal communication).
We concluded that the properties of these mutants would
complicate any interpretation of their phenotype with respect
to SAPK activation, and they were not analyzed.
The role of SAPK activation in HSV infection is not well
understood. Inhibition of JNK localization to the nucleus and
inhibition of JNK and p38 activity by specific inhibitors result
in significantly reduced virus yields (56; Hargett, McLean, and
Bachenheimer, unpublished observations). A number of func-
tional targets of p38 and JNK might be expected to contribute
to efficient virus replication. In the nucleus, MAPKAP kinase
and transcription factors ATF-2 and Elk-1 are activated by p38
(24, 77, 88, 90, 94, 95). In the cytoplasm, MNK1, a serine/
threonine kinase related to MAPKAP kinase, is phosphory-
lated by p38 (25) and, once activated, phosphorylates eIF4E,
the cap-binding component of the eIF4F multiprotein complex
(20, 46, 61). Mitogen- and stress-activated kinase (MSK),
which phosphorylates the chromatin-associated proteins his-
tone H3 and high-mobility-group 14 (HMG-14) to promote
gene expression, is also activated by p38 (17, 64). JNK activates
a number of transcription factors, including c-Jun, p53, ATF-2,
NFAT, ELK-1, and SAP-1 (2, 15, 30, 37, 38, 96).
Apoptosis is also regulated by JNK-mediated phosphoryla-
tion of Bcl-2 family members, p53, and c-Myc (2, 37, 45, 63).
Interestingly, Bcl-2 is extremely unstable in ICP27 mutant-
infected cells (97), serving as preliminary evidence that JNK
activation in HSV-infected cells may contribute to apoptosis
suppression. NF-B is translocated to the nucleus during in-
fection, accompanied by degradation of IB (3, 66). Infection
with an ICP27 mutant failed to activate the NF-B pathway
(28, 33, 66). Of interest in this regard is that NF-B activation
can also occur through cross talk from the MEKK1/p38 (93) or
by a p38/casein kinase 2-dependent C-terminal phosphoryla-
tion of IKK and IKK (44). Activation of the SAPK pathways
under certain conditions causes cell cycle arrest. Arrest of cells
in G1 is associated with p38 regulation of cyclin D1 levels, as
p38 targets cyclin D1 for proteosomal degradation (12) and
negatively regulates the cyclin D1 promoter (50). JNK is also
reported to block cell cycle progression at G2/M by phosphor-
ylating Cdc25, the phosphatase necessary for activating cyclin
B/CDK2 complexes (29). Therefore, JNK and p38 activation
may be sufficient for suppression of both the cell cycle and
apoptosis during HSV infection.
Though induction of certain SAPK-induced transcription
factors, ATF-2, c-Jun, and AP-1, during HSV infection has
been reported (56, 97), the impact of these activations on
cellular and viral gene expression has not been fully described.
Inhibition of p38 kinase activity by treatment of infected cells
with the specific inhibitor SB203580 did not affect the viral
transcription program (43). Many of the downstream effectors
of SAPK activation are currently under investigation to gain a
clearer model for the importance of ICP27-dependent phos-
phorylation of p38 and JNK in the virus life cycle. A recent
report identified a p38-dependent activation of MK2 through
the Kaposi’s sarcoma-associated herpesvirus latency protein
kaposin B, which plays a role in the stabilization of cytoplasmic
mRNA to allow increased translation of messages with AU-
rich elements (53). Interleukin-6 and granulocyte-macrophage
colony-stimulating factor, which contain AU-rich elements in
their mRNAs, are expressed to higher levels in cells expressing
kaposin B (53). Since we here identified p38-dependent MK2
phosphorylation in HSV infection, mRNA stabilization through
AU-rich elements may prove to be another posttranscriptional
control of viral protein expression by ICP27.
Both DNA and RNA viruses activate MAPK pathways dur-
ing infection. Apart from the Herpesvirdae family, human im-
munodeficiency virus, simian immunodeficiency virus, influ-
enza A virus, murine hepatitis virus, encephalomyocarditis
virus, respiratory syncytial virus, murine coronavirus, and hep-
atitis B and C viruses all activate one or more MAPK pathway
to enhance viral replication, inflammation, or pathogenesis (8,
23, 41, 42, 49, 54, 62, 84, 89). The activation of p38 during
infection also stimulates cellular and viral protein synthesis.
Murine coronavirus stimulates cellular and viral translation
through a p38-dependent increase in eIF4E phosphorylation
(7). Encephalomyocarditis virus RNA translation is suppressed
in the presence of p38 inhibitor (34), and respiratory syncytial
virus-induced RANTES production is translationally regulated
by p38 (67). Efficiency of translation in HSV-1-infected cells is
also reported to be regulated by p38-dependent eIF4E phos-
phorylation (92). While this effect was reported to depend on
functional ICP0, the results reported here and other results
(Hargett and Bachenheimer, unpublished observations) sug-
gest the direct requirement for ICP27. One of our future ef-
forts will be directed at resolving this discrepancy.
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